InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PBT | Ann: Prana Biotechnology EGM and Conference Call Facility | 28/03/19 | 3 | 448 | |||
|
|||||||
PBT | shorts up 3.5% | 27/03/19 | 0 | 102 | |||
|
|||||||
PBT | Alzheimers and metals | 26/03/19 | 1 | 178 | |||
|
|||||||
PBT | Prana stock movement | 25/03/19 | 26 | 8.2K | |||
|
|||||||
PBT | Iron / tau in neurodegeneration | 23/03/19 | 0 | 121 | |||
|
|||||||
PBT | apoE4-associated mitochondrial dysfunction | 23/03/19 | 0 | 183 | |||
|
|||||||
PBT | Biogen down 30%, aducanumab failed in AD | 22/03/19 | 4 | 1.0K | |||
|
|||||||
PBT | Ann: Appendix 3B | 21/03/19 | 2 | 439 | |||
|
See All Discussions